Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051584
Status:
TERMINATED
Last Update Posted:
2011-10-24
First Post:
2003-01-13
Brief Title:
SafetyEfficacy Study of SGN-15 Antibody-Drug Conjugate Combined With Gemcitabine in Patients With Ovarian Cancer
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-05
Completion Date Type:
ACTUAL
First Submit Date:
2003-01-13
First Submit QC Date:
January 14 2003
Study First Post Date:
2003-01-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-10-21
Last Update Post Date:
2011-10-24
Last Update Post Date Type:
ESTIMATED